The Discounted Cash Flow (DCF) valuation of Cara Therapeutics Inc (CARA) is (3,063.48) USD. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on DCF is -57684.2%.
Based on the latest price of 5.32 USD and our DCF valuation, Cara Therapeutics Inc (CARA) is a sell. selling CARA stocks now will result in a potential gain of 57684.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.5% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (15,760.25) - (1,698.23) | (3,063.48) |
| Upside | -296345.3% - -32021.7% | -57684.2% |